| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |